Last reviewed · How we verify
OLX72021
At a glance
| Generic name | OLX72021 |
|---|---|
| Sponsor | Olix Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- OLX72021 CI brief — competitive landscape report
- OLX72021 updates RSS · CI watch RSS
- Olix Pharmaceuticals, Inc. portfolio CI